Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.
- 28 February 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (5) , 1530-1534
- https://doi.org/10.1073/pnas.92.5.1530
Abstract
Tuberculosis, caused by the intracellular pathogen Mycobacterium tuberculosis, is the world's leading cause of death in humans from a single infectious agent. A safe and effective vaccine against this scourge is urgently needed. This study demonstrates that immunization with the 30-kDa major secretory protein, alone or in combination with other abundant extracellular proteins of M. tuberculosis, induces strong cell-mediated immune responses and substantial protective immunity against aerosol challenge with virulent M. tuberculosis bacilli in the highly susceptible guinea pig model of pulmonary tuberculosis. Protection is manifested by decreased clinical illness including decreased weight loss, reduced mortality, and decreased growth of M. tuberculosis in the lungs and spleens of immunized animals compared with sham-immunized controls. This study demonstrates that purified major extracellular proteins of M. tuberculosis are candidate components of a subunit vaccine against tuberculosis and provides compelling support for the concept that extracellular proteins of intracellular pathogens are key immunoprotective molecules.Keywords
This publication has 21 references indexed in Scilit:
- The global tuberculosis situation and the new control strategy of the World Health OrganizationPublished by Elsevier ,2004
- Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited.The Journal of Experimental Medicine, 1995
- Major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires' disease.Journal of Clinical Investigation, 1993
- Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosisMolecular Microbiology, 1991
- Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.The Journal of Experimental Medicine, 1989
- The BCG Story: Lessons from the Past and Implications for the FutureClinical Infectious Diseases, 1989
- Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71 kD antigen, a member of the 70 kD heat‐shock protein familyMolecular Microbiology, 1989
- Protection to mice afforded by bcg vaccines against an aerogenic challenge by three mycobacteria of decreasing virulenceTubercle, 1985
- Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.The Journal of Experimental Medicine, 1983
- RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMESThe Journal of Experimental Medicine, 1971